A ngiotensin II (Ang II) has many physiological and pathological effects on smooth muscle cells (SMCs) of aortic tissue both in vitro and in vivo. Most studies on cultured aortic SMCs have isolated cells from the thoracic region of rats. [1] [2] [3] In these cells, Ang II consistently promotes hypertrophy, 1,2 with a lesser number of studies demonstrating a proliferation response. 3 The relative effects of Ang II on hypertrophy versus proliferation, in vitro, appear to depend on culture conditions, such as confluence and the coincubation with specific cytokines. 3 The expression of the cyclindependent kinase inhibitor p27 kip1 , in cultured cells, is a factor determining the relative effect on hypertrophy versus proliferation. 4 Many Ang II-induced responses on SMCs are attributable to stimulation of NADPH oxidase with the subsequent generation of reactive oxygen species (ROS). [5] [6] [7] These include Ang II-induced hypertrophy and proliferative responses. NADPH oxidase is a multimeric complex. SMCs express specific isoforms of gp91 phox , with nox1 being the principal regulator of Ang II-induced responses. 8 -10 The activity of nox1 is regulated by the presence of p47 phox . 11 Consistent with the nox1-p47 phox axis, deficiency of p47 phox blunts Ang II-induced increases in systolic blood pressure (SBP). 12 More recently, the dominant-negative helix-loop-helix, inhibitor of differentiation 3 (Id3), has been invoked as a regulator of redox-mediated Ang II induced proliferation. 13, 14 Ang II effects on aortic contractile responses have provided insight that this octapeptide has region-specific effects. Ang II does not induce contractions of mouse aortic rings isolated from thoracic tissue, but generates a large transient contraction in abdominal tissue in vitro. 15, 16 Contractions of aortic rings are mediated by angiotensin II type 1b (AT 1b ) receptors despite the presence of AT 1a receptors, which may be indicative of divergent signaling mechanisms stimulated by these subtypes. 15, 16 Region-specific effects on aorta have been noted in response to other bioactivators such as transforming growth factor-␤. 17, 18 These region-specific effects may be attributable to the phenotypic diversity of aortic SMCs that arise as a consequence of heterogeneity of embryological origin. 19 Ang II infusion, in vivo, is well known to promote changes in medial aortic SMCs via mechanisms that are independent of increased systolic blood pressure. 20 The aim of the present study was to determine whether Ang II infusion in vivo promoted heterogeneous effects on SMC growth and/or proliferation throughout the entire aorta. Despite previously described differences in contractile activity of Ang II on thoracic versus abdominal aorta, 15, 16 we were unable to demonstrate morphological differences in these two regions during Ang II infusion. However, the ascending aorta has a different response than the rest of the aorta with a medial expansion that was attributable to hyperplasia, versus hypertrophy in other regions. Aortic medial expansion throughout the aorta was ablated by deficiency of p47 phox , whereas deficiency of Id3 inhibited the hyperplasia induced by Ang II in the ascending aorta.
Methods
AT 1a receptor-deficient (B.129P2-Agtr1a tm1UNC ), C57BL/6, and p47 phox mutant [B6(Cg)-Ncf1 m1J /J, C57 p47/p47 ] mice were purchased from The Jackson Laboratory. Id3-deficient mice were a generous gift from Dr Zhang (Duke University). All studies were conducted using male mice with littermate controls.
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results

Ang II Infusion Uniformly Increased Aortic Thickening via AT 1a Receptors, Independent of Pressure
Ang II infusion (1000 ng/kg per minute) into C57BL/6 mice led to a sustained increase in SBP (Ϸ40 mm Hg) during the 28 days of delivery ( Figure 1A ). Ang II infusion also led to increased medial thickness and area to a similar percent in all aortic regions ( Figure 1B and Online Table I ). To determine the contribution of pressure per se to medial expansion, norepinephrine (NE) was administered to male C57BL/6 mice at doses that increased systolic blood pressure by the same magnitude as Ang II (approximately 40 to 50 mm Hg).
Contrary to Ang II infusion, NE administration led to no significant changes in medial thickness compared to age-, gender-, and strain-matched mice infused with saline. Equivalent data were also obtained by increasing blood pressure through administration of N -nitro-L-arginine methyl ester (data not shown).
To define whether Ang II-induced medial thickening was mediated through AT 1a receptors, similar experiments were performed in AT 1a receptor Ϫ/Ϫ mice. Plasma renin concentrations were markedly increased in saline-infused AT 1a receptor Ϫ/Ϫ mice compared to C57BL/6 wild type controls (Online Table I receptor Ϫ/Ϫ mice ( Figure 2A ). Moreover, infusion of Ang II did not change aortic medial thickness or area in AT 1a receptor Ϫ/Ϫ mice ( Figure 2B and Online Table I ). Infusion of NE increased SBP in AT 1a receptor Ϫ/Ϫ mice ( Figure 2A ). However, NE infusion had no effect on plasma renin concentrations or medial dimensions in any aortic region of AT 1a receptor Ϫ/Ϫ mice ( Figure 2B and Online Table I ).
The Basis of Ang II-Induced Medial Thickening Differed Among Aortic Regions
Medial thickening with Ang II infusion was associated with a marked expansion of the intralaminar space in all aortic regions ( Figure 3 ). This expansion may potentially be attributable to contributions from extracellular matrix expansion, and SMC hypertrophy or hyperplasia. To determine the contribution of extracellular matrix, aortas were stained with Movat's pentachrome to permit visualization of elastin, collagen, and proteoglycans (Online Figure III ). There were no overt differences in staining for extracellular matrix components. Serial sections from all regions were immunostained for ␣-actin or stained with propidium iodide to access expansion of cell size and number, respectively ( Figure 3 ). Immunostaining for ␣-actin demonstrated uniform reactivity throughout the intra laminar spaces ( Figure 3A ). Nuclei counts were normalized to a standard section length, because the medial expansion confounded the utilization of vessel area. Ang II infusion did not significantly affect nuclei density in both thoracic and abdominal aortic regions ( Figure 3B ). When combined with data from immunostaining, this was consistent, with the medial expansion being attributable to increased volume of SMCs. Unexpectedly, Ang II promoted a marked increase in nuclei density in tissue sections from the ascending aorta ( Figure 3B ). Because this entire region immunostained positively for SMCs, this was consistent with medial expansion caused by hyperplasia. Ang II also exerted region-specific effects on cultured SMCs. In agreement with the observations in vivo, Ang II promoted a proliferation of SMCs cultured from ascending aortas, but not in SMCs isolated from other aortic regions (Online Figure IV) . Platelet-derived growth factor-BB promoted similar proliferation in SMCs cultured from all aortic regions. Therefore, the basis for Ang II-induced medial expansion differed among aortic regions.
Ang II-Induced Growth Suppression Is Unchanged Among Aortic Regions
The previous data demonstrate Ang II induction of vascular growth and proliferation. However, Ang II can also act as a potent growth suppressor. Therefore, we evaluated apoptotic events via TUNEL. SMCs cultured from different aortic regions significantly increased apoptotic events with the addition of Ang II versus saline (Ϸ10-fold); however, there was no difference between the four regions (Online Figure V) . These data do not support differences in Ang II-induced growth suppression among the aortic regions.
p47 phox Deficiency Ablated Ang II-Induced Medial Thickness
Given the role of Ang II-induced ROS on SMC hypertrophy and hyperplasia, and the above region-specific data, we examined whether concentrations of superoxide (O 2 . ) and hydrogen peroxide (H 2 O 2 ) differed along the aorta. In SMCs cultured from different aortic regions, there was uniform expression of ROS in all aortic regions examined (Online Figure VI) . Furthermore, in vivo and ex vivo measurement of aortic O 2 . demonstrated no regional differences throughout the aorta (Online Figure VII) . To determine whether inability to generate ROS resulted in functional changes in vivo, saline, Ang II, or NE was infused into mice with a spontaneous loss of functional mutation for p47 phox . Basal blood pressure was not different between p47 phox -deficient mice compared to wild type (C57BL/6). Ang II infusion did not increase blood pressure initially in p47 phox functionally deficient mice (Figure 4 ), but did result in a belated increase during week 4 of infusion. Plasma renin concentrations were unchanged in saline-infused p47 phox -deficient compared to wild type mice, and infusion of Ang II led to similar reductions in plasma renin concentrations in p47 phox -deficient mice (Online Table I ). The functional deficiency of p47 phox had no effect on the ability of NE infusion to increase SBP ( Figure 4A ). The absence of functional p47 phox abolished Ang II-induced increases in medial thickness for all regions of the aorta ( Figure 4B ).
Ang II Initiated Id3 Translocation to Nuclei
To provide a basis for Ang II-induced medial SMC hyperplastic response that was limited to the ascending portion of aortas, we defined the expression of Id3. Real-time PCR analysis of Id3 mRNA demonstrated significantly increased (3.5 fold) abundance in ascending aortas versus other aortic regions ( Figure 5A ). Western blotting of Id3 protein in cultured SMCs revealed similar regional differences in the aorta (Figure 5B through 5D ; Online Figure VIII) . As noted previously, 21 Id3 abundance fluctuated over time in the presence of serum, but was always greater in cells isolated from the ascending region. Furthermore, Ang II incubation of SMCs isolated from ascending aortas resulted in Id3 colocalization within nuclei at 1 and 24 hours, with cycling to the cytoplasmic compartment at 12 hours (Online Figures IX  through XI) . This effect was not observed in other aortic regions (Online Figure XI) . These data demonstrate Ang II initiates cyclic Id3 localization to the nuclei compartment of SMC in the ascending aorta, suggesting novel mechanisms whereby Id3 mediates the regional hyperplastic effects of Ang II.
Id3 Deficiency Ablated Ascending Aortic Hyperplasia
To determine the in vivo contribution of Id3 to Ang IIinduced ascending aortic hyperplasia, Id3 Ϫ/Ϫ mice were infused with either saline or Ang II. Ang II markedly increased SBP in Id3 Ϫ/Ϫ mice ( Figure 6A ). Furthermore, Id3 deficiency did not abolish Ang II-induced increases of medial thickness in the ascending and abdominal regions ( Figure 6B ). Similar to Id3 ϩ/ϩ mice, immunostaining of aortas from Id3 Ϫ/Ϫ mice with ␣-actin demonstrated uniform reactivity throughout the intralaminar spaces and no overt matrix deposition by Movat's pentachrome staining (data not shown). Moreover, plasma renin concentrations were similarly reduced by Ang II infusion in Id3 Ϫ/Ϫ mice, compared to other mouse strains (Online Table I ). SMC nuclei density was unchanged in other aortic regions compared to wild type mice (data not shown). However, Ang II-induced increases in ascending aortic SMC nuclei density were strikingly reduced by Id3 deficiency (Figure 7) .
Discussion
This study demonstrated that Ang II promoted a uniform medial expansion throughout the aorta. Despite the unifor- mity of the expansion, the underlying cause differed in a region-specific manner. SMC hyperplasia occurred in the ascending aorta, but SMC's hypertrophied in all other aortic regions. This effect was attributable to stimulation of AT 1a receptors, but independent of increases in SBP. Ang IIinduced medial expansion was ablated in all aortic regions in mice with functional deficiency of p47 phox , whereas the hyperplastic response localized to the ascending aorta was inhibited by deficiency of Id3.
Ang II-induced medial expansion has the potential to be attributable to both cellular and extracellular components. Although Ang II is known to increase several extracellular matrix proteins, including collagen 22, 23 and proteoglycans, 24 these did not appear to provide a major contribution to medial expansion. Therefore, this study focused on the contributions of increases in cellular components to medial expansion. Many studies have demonstrated that Ang II promotes hypertrophy 1,2 of cultured aortic SMCs, with a lesser number demonstrating proliferation. 3 Most of these studies have been performed with SMCs that have been derived from rat thoracic aorta. A lesser number of studies have chronically infused Ang II in vivo to determine effects on medial dimensions. [25] [26] [27] SMC proliferative responses to Ang II infusion have been demonstrated in rat carotid and mesenteric arteries. 20,28 -30 In contrast, the predominance of studies have demonstrated Ang II increased medial thickness in vivo through hypertrophy of rat 25, 26, 28 and mouse 10, 27, 31 aortas. The location of aortic sections used in these studies has not been commonly stated, but is likely to be the thoracic region. Thus, the description of medial expansion being attributable to hypertrophy in the thoracic aorta is consistent with the present study. Our results are the first to describe heterogeneity of Ang II-induced responses within the aorta. Results from this study demonstrated that Ang II-induced proliferation was limited to SMCs cultured from the ascending aorta versus other aortic regions. However, the present study did not discern whether the in vivo increase in nuclei was attributable to proliferation or polyploidization, although the magnitude of the increase in nuclei in the ascending aorta is much larger than has been described for polyploidization. 25, [32] [33] [34] The basis for the heterogeneous cause of Ang II-induced medial expansion in different regions of the aorta may be attributable to the diversity of embryonic origin of SMCs with potential functional differences. 19 SMCs in the ascending aortic regions are primarily of neural crest origin, which extends from the aortic root to just distal of the subclavian artery. 35 This same lineage also extends to the carotid arteries. Conversely, thoracic and abdominal aortic SMCs are derived from somite and splanchnic mesoderm lineages, respectively. Regional differences in aortic SMCs have been described previously. 19 Deficiency of AT 1a receptors ablated Ang II-induced medial expansion in all regions. Previous studies have highlighted the role of the AT 1b receptor subtype in aortic function. 15, 36 Although both a and b subtypes of AT 1 receptors are expressed in the mouse aorta, deficiency of the b subtype substantially reduced Ang II-induced contractions that are restricted to the abdominal aorta. 16 Although the 2 subtypes are highly homologous, the differences are predominantly in the final intracellular loop and the cytoplasmic tail of this seven membrane spanning protein. 37 These amino acid substitutions have predictive differences on intracellular signaling. 38, 39 Thus, in future studies, the relative differences between the subtypes will provide insight into the definition of the intracellular pathway that leads to medial expansion.
As with previous studies, absence of AT 1a receptors had no effect on basal SBP in mice on a C57BL/6 background. 40 -42 Moreover, AT 1a receptor deficiency increased plasma renin concentrations, demonstrating removal of Ang II-mediated negative feedback on renin synthesis and secretion. 43 This maintenance of pressure is probably attributable to the continued presence of AT 1b receptors, because compound deficiency of both subtypes promotes a severe phenotype as occurs with deficiency of angiotensinogen, renin, or angiotensin-converting enzyme. 43 The presence of functional AT 1b receptors can be inferred in the present study by the downregulation of plasma renin concentrations during Ang II infusion into AT 1a receptor-deficient mice and its reversal 10, 27, 31 NADPH oxidases are multimeric complexes with components that differ in a cell-specific manner. In regard to Ang II-induced responses in SMCs, these are mediated by a complex containing nox1 in which p47 phox is a critical component for activation. 11 The importance of this coupling has been shown using gp91ds-tat, which is a peptide that inhibits the assembly of Nox1 with p47 phox . 46 Gp91ds-tat inhibits Ang II-induced increases in SBP and medial expansion of carotid arteries. Conversely, deficiency of p47 phox attenuates Ang IIinduced increases in SBP. 12, 47 In contrast to results from the present study, a previous study demonstrated that p47 phox deficiency increased basal blood pressure, even though Ang II-induced increases in SBP were attenuated. 48 Moreover, p47 phox -deficient mice showed basal increases in renin, 48 which we were not able to demonstrate. Differences in results may arise from the mode of interference with p47 phox , because the previous study used genetically engineered p47 phox -deficient mice, whereas the present study used p47 phox -deficient mice that arose from a spontaneous mutation. 49 Although the spontaneous and engineered mutations are on exon 8 and 7, respectively, there is no obvious basis for these mice exhibiting different manifestations of deficiency. In contrast to the spontaneous mutation, engineered p47 phox -deficient mice have been shown previously to exhibit no change in basal SBP. However, other studies have demonstrated a greater effect on SBP during Ang II infusion than in the present study. 12, 50 This greater efficacy of Ang II-induced increases in SBP may be a consequence of the use of the [Val5] variant of Ang II which has a greater efficacy at stimulating AT 1 receptors compared to the Ang II sequence of human and mouse peptides. Irrespective of these differences among studies, the present study demonstrated that deficiency of p47 phox ablated aortic medial expansion in all regions.
Ang II-induced proliferation of cultured SMCs occurs via activation of NADPH oxidase with generation of superoxide production that subsequently induces the ex- pression of the dominant-negative helix-loop-helix protein Id3. 13, 14 Id3 dimerizes with the basic helix-loop-helix factor E47, inhibits E47-induced activation of expression of cyclin dependent kinase inhibitor p21 WAF1/Cip1 , and promotes SMC proliferation. 21 This mitotic effect is mediated via nuclei translocation of Id3 from the cytoplasm via an E47 nuclear localization signal. 51, 52 Id3 has also been implicated in proliferative responses to carotid artery injury. 53 As noted earlier, the carotid artery shares common embryonic origin with cells of the ascending aorta. 19, 35 In agreement with the disparity of the ascending aorta versus other aortic regions, Id3 mRNA and protein abundance was much greater in this region. In contrast to previous reports using rat thoracic SMCs, in this study Ang II did not upregulate Id3 protein levels in mouse SMCs. 13 In contrast, we demonstrate that Ang II signaling can initiate Id3 localization to the nuclei compartment at 1 and 24 hours. Previous data demonstrated Id3 was upregulated and phosphorylated at these intervals in correlation with cell cycle progression. 21 Furthermore, direct evidence of a role of Id3 in the hyperplastic response to Ang II was derived from mice with genetic deficiencies of this protein.
Although there is the potential for Id3 deficiency to lead to compensatory increases of other Id proteins, the total ablation of Ang II-induced hyperplasia of the ascending aorta provided a striking demonstration of the specific requirement for Id3. Moreover, effects of Id3 deficiency on Ang II-induced proliferative responses were observed despite a marked increase in the blood pressure response to Ang II, supporting pressure-independent effects of Ang II on SMC proliferation.
In summary, this study demonstrated that Ang II infusion promotes aortic medial expansion by disparate mechanisms in a region-specific manner. A major difference was the demonstration of the disparity of responses in the ascending aorta compared to other regions. Unique responses of this region in aortic luminal expansion have also been demonstrated in mice harboring fibrillin-1 mutations that were infused with Ang II. 54 Although this study defined Ang II-induced changes in SMCs, this effect could be directly on SMCs or indirectly from another cell type. For example, endothelial cells secrete a wide range of products that directly affect SMC function. Recent data implicate platelet-derived growth factor-DD secretion from endothelial cells as a moderator of SMC phenotypic modulation, particularly in areas of disturbed blood flow such as the aortic arch. 55 Thus, subsequent studies will determine the contribution of SMC and endothelial cells to the observed phenotypes by using Cre-Lox technology to promote cell-specific AT 1a receptor deficiency. 
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